Similarly, ovarian cancers with high levels of EDD may be more likely to survive cytotoxic chemotherapy, for example, via the interaction between EDD and the critical DNA damage cell cycle checkpoint kinase CHK2 (Henderson et al, 2006). The gene discussed is CHEK2; the disease is ovarian carcinoma.